Breast Cancer

  • Anna K. Paulsson
  • Tracy Sherertz
  • Catherine C. ParkEmail author


This chapter will discuss the management of DCIS, early-stage, and locally advanced breast cancers, with an emphasis on radiation therapy technique and published data.


Breast cancer DCIS Whole breast radiotherapy Partial breast radiotherapy Postmastectomy radiotherapy 


  1. Bartelink H, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25(22):3259–65.CrossRefGoogle Scholar
  2. Bartelink H, et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomized phase 3 trial. Lancet Oncol. 2015;16(1):47–56.CrossRefGoogle Scholar
  3. Chen RC, et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management--a systematic review. J Clin Oncol. 2008;26(30):4981–9.CrossRefGoogle Scholar
  4. Collins LC, et al. Risk prediction for local breast cancer recurrence among women with DCIS treated in a community practice: a nested, case-control study. Ann Surg Oncol. 2015;22:S502–8.CrossRefGoogle Scholar
  5. Correa C, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence based consensus statement. Pract Radiat Oncol. 2017;7(2):73–9.CrossRefGoogle Scholar
  6. Early Breast Cancer Trialists’ Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomized trials. Lancet. 2014;383:2127–35.Google Scholar
  7. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20(20):4141–9.CrossRefGoogle Scholar
  8. Freedman GM, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist. Int J Radiat Oncol Biol Phys. 2000;46(4):805–14.CrossRefGoogle Scholar
  9. Hughes KS, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. NEJM. 2004;351:971–7.CrossRefGoogle Scholar
  10. Mamounas EP, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and bowel project B-18 and B-27. J Clin Oncol. 2012;30(32):3960–6.CrossRefGoogle Scholar
  11. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–55.CrossRefGoogle Scholar
  12. Owen JR, et al. Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cacer after local tumor excision: long-term results of a randomized trial. Lancet Oncol. 2006;7(6):467–71.CrossRefGoogle Scholar
  13. Recht A, et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19(5):1539–69.CrossRefGoogle Scholar
  14. Recht A, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology and Society of Surgical Oncology focused guideline update. J Clin Oncol. 2016;34(36):4431–42.CrossRefGoogle Scholar
  15. Rudloff U, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.CrossRefGoogle Scholar
  16. Shah C, et al. The American Brachytherapy Society Consensus statement for accelerated paratial breast irradiation. Brachytherapy. 2013;12(4):267–77.CrossRefGoogle Scholar
  17. Silverstein MJ, et al. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186(4):337–43.CrossRefGoogle Scholar
  18. Smith BD, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987–1001.CrossRefGoogle Scholar
  19. Strnad V, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. 2016;367(10015):229–38.CrossRefGoogle Scholar
  20. Sweldens C, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014;20(1):1–7.CrossRefGoogle Scholar
  21. Thorsen LB, et al. DBCG-IMN: a population-basec cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34(4):314–20.CrossRefGoogle Scholar
  22. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet. 2010;376:91–102.Google Scholar
  23. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomized trial. Lancet. 2014;383:603–13.CrossRefGoogle Scholar
  24. Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–50.Google Scholar
  25. Veronesi U, et al. Intraoperative radiotherapy versus external radiotherapy early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14(13):1269–77.CrossRefGoogle Scholar
  26. Wang F, et al. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast. Clin Oncol (R Coll Radiol). 2014;26(11):684–91.CrossRefGoogle Scholar
  27. White J, et al. Long-term cancer outcomes from study NRG oncology/RTOG 9517: a phase 2 study of accelerated partial breast irradiation with multicatheter brachytherapy after lumpectomy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2016;95(5):1460–5.CrossRefGoogle Scholar
  28. Yi M, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012;30(6):600–7.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Anna K. Paulsson
    • 1
  • Tracy Sherertz
    • 1
  • Catherine C. Park
    • 2
    Email author
  1. 1.Department of Radiation Oncology, University of California San FranciscoSan FranciscoUSA
  2. 2.Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive CancerSan FranciscoUSA

Personalised recommendations